Bafna Lifestyles Remedies becomes subsidiary of Bafna Pharmaceuticals

03 Aug 2011 Evaluate

Bafna Lifestyles Remedies has become a subsidiary company of Bafna Pharmaceuticals in accordance with the provisions of the Companies Act, 1956. Recently, Bafna Pharmaceuticals had concluded the deal with NR Jet, an affiliate of Johnson & Johnson and had acquired the well established pharmaceutical brand “RARICAP”. The brand “RARICAP” has a legacy of over 40 years in the market. It is prescribed for iron deficiency anemia in women - especially during pregnancy.

Bafna Pharmaceuticals started its production with tablets facility and subsequently added capsule and oral syrup facilities respectively. BAFNA always focused on institutional and generic supply to keep its production line busy. It also concentrated on registering its products in the international market.

Bafna Pharma Share Price

94.77 -4.98 (-4.99%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.